I reach the pinnacle of life by learning

Durant National Center for Gene Therapy Research, USA.

Dr. Jonathan, the director of the research center, sat at the top with a serious face.

Beside him is the deputy director of the Pentagon Intelligence Agency.

For this meeting, they called many scholars.

These scholars are not only from the United States, but also from Germany, Japan, Britain, France and other countries.All are industry leaders in genetics, genomics, oncology and other fields.

There are several Nobel laureates sitting here.

Professor Martin, who was called from Cold Spring Harbor, was very dissatisfied: "My time is precious. If there is nothing serious, I will be angry."

Jonathan looked serious: "It is indeed important to call everyone here this time."

"Let me do it, Dr. Jonathan." The deputy director said, "In just two months, Huaguo withdrew from the United Nations ICGEB and unilaterally tore up the agreement. We have issued a strong condemnation from the international public opinion! And terminated Cooperation with China in this field."

The effect is very significant.

Many enterprises in Huaguo are worried about this, and they don't understand why the country has taken this move.

Isn't this giving someone a handle?

Enterprises in China, especially those that do more foreign exchange, many leaders have crooked buttocks.

Foreign exchange is good, foreign exchange makes money.What you earn is still in US dollars, which is more expensive.

It is really unfilial to bow down to foreign adults, submissive, and call you father; in China, it is really unfilial to attack your real parents.

Because of the sweater wars in recent years, these foreign exchange companies have had a hard time and lost a lot of money.

These state-owned enterprise executives are already admonishing their superiors, euphemistically expressing the hope that they can cede land for peace as soon as possible, and don't make too many fools.

However, this time, Hua Guo's attitude was very firm.

The United States wanted to see how long they could be tough, but they didn't expect a piece of news from the intelligence spies that shocked them.

The deputy director asked: "I know that there is a targeted drug called a multi-target inhibitor, which is an inhibitor that can act on multiple targets at the same time. I would like to know if there is such a targeted drug that can treat human beings. Does it work for all cancers?"

Mike, who sat in the middle and back row, said, "Impossible, unless it's in a dream. There is no such medicine in the world!"

Martin: "There are already examples of multi-target inhibitors, such as sunitinib, but the side effects are high. And it is only effective for liver cancer.

"One of my students, when he was studying communication in Cold Spring Harbor, once proposed a very interesting idea. Let non-drug cytotoxic agents attach to T cells, follow the T cells to dissociate, look for mutated cells in the human body, and release the drugs ...

"But we discussed it for a long time at the time. With the current level of medicine and biology, this kind of thing is impossible. If it can be developed, it will at least surpass the level of existing genetic technology for 100 years..."

Professor Martin deserves to be the man who kicked off the era of biological genes with JD Watson.

Speak well and convincingly.

The other doctors also nodded in agreement.

At this moment, the deputy director took a deep breath: "Is that student of yours from Huaguo?"

Martin was taken aback: "How do you know?"

Qiao Yu is indeed from Huaguo.

The deputy director's face was serious: "We just received the news. Huaguo has developed a new drug, which has not yet been named. The general name is T cell adhesion agent STI-217. It is called a 'universal targeted drug'."

"This is why they have the confidence to withdraw from ICGEB. I heard that the first phase of clinical trials is about to be completed."

"Are you kidding? Any proof?"

"No. The guards in Huaguo are very strict, and we have lost many excellent intelligence agents."

"Can the intelligence bureau stop collecting such mindless intelligence all the time. Please, are you using Chinese netizens as intelligence agents?"

"I can write you a 3000-word paper right now, demonstrating the infeasibility of this news from the existing technology." A Nobel Prize winner proudly said.

As soon as this remark came out, the air was filled with joy and laughter.

Only Professor Martin, with white beard and hair, was sitting in his original position, holding his hands together, covering half of his face, with deep eyes.

In June, although she didn't need to go to class, Qiao Yu still returned to the school she had been away for a long time.

When passing by the school ATM machine, he thought for a moment and took out the bank card issued by the state when he left the Third Hospital.

The balance is mixed.

Two years of salary plus performance, there are more than three million.

For Yanda science and engineering professors, it is not particularly difficult to obtain 300 million research funds.

The hard part is earning 300 million.

You know, the current salary of Yanda professors plus various subsidies is only in the early fifteen or sixties per month.

Qiao Yu thought for a while and asked the system: "How much money have you made from cutting capitalist leeks on Wall Street in the past few years?"

At the beginning, Qiao Yu gave the system a principal of 100 million knives, and Qiao Yu seldom intervened after that.

System: "Fortunately, it's less than [-] million now."

"How many?"

"3400 knives."

In other words, it's almost [-] million.

When money reaches a certain amount, it is really just a number.

Qiao Yu thought for a moment: "Let Xun'an Pharmaceutical go into operation, and set up a prize. I can't spend so much money anyway. It's called the Xun'an Prize, and it rewards young talents in the fields of biology and mathematics, under the age of 40. The requirement is Hua Nationality."

The system was stunned: "That's fine, how much is the bonus?"

"How much is the Nobel prize?"

"1000 million crowns, equivalent to 140 million U.S. dollars."

"The security award is 1000 million RMB."

Qiao Yu has always felt that all domestic awards are a bit stingy.

For example, Huaguo's highest technology award is only 500 million.

This has led to the fact that most scholars doing scientific research have been in a state of unequal income and education for a long time.

It does not mean that the higher the degree, the more money you will earn.It's that the ratio of pay and reward is very out of balance.

Perhaps the requirements for scientific researchers are too high, and they always hope that what they eat is grass and what they squeeze out is milk.

The state allocated a villa to Academician Yuan, and some people shouted and shouted on the Internet.

Qiao Yu himself is also doing scientific research. He lives a good life and never lacks scientific research funding.

But it does not mean that he is not clear about the current status of the domestic scientific research community.

Being poor cares themselves, being wealthy cares the world.

However, Qiao Yu still needs to think about how to operate it.To set up an award, it is a long process from approval to committee formation to having credibility.

Anyway, he has nothing to do these days.

For Qiao Yu's return, Master and students of Yan expressed their warm welcome.

In their understanding, Qiao Yu's professors had only studied abroad for two years.

As for whether you go to the Cold Spring Harbor Laboratory on Long Island or the Lawrence Burke Laboratory at the University of California, for most people, it doesn't matter.

Professor Tan Zirui took a three-month long vacation, and it is estimated that he will not come back until the next semester starts.

Qiao Yu thought about it for a while, this semester is coming to an end, it's not good to take the place of other teachers and teach the students.

However, the previous two consecutive years of experiments were really nauseating, and I don't really want to start a new topic for the time being.

So, he set his sights on other weak professors in the School of Biological Sciences.

Today, go to Professor Kou's laboratory.

Tomorrow, go to Professor Zhang's laboratory.

Qiao Yu said: "I didn't expect to see you in two years, and you have been rated as a Changjiang scholar."

His tone was very gratifying.

Zhang Kaiwei replied with a smile: "Hey, I'm still old, and I'm living on my laurels. I haven't had any research results recently. I really miss the days when I was doing experiments with you."

When Zhang Kaiwei faced Qiao Yu, he even used honorifics unknowingly.

Qiao Yu: "My work schedule for this year is full, and I don't have any ideas for the time being. Let's see next year."

While talking, Qiao Yu's phone rang.

He turned on the phone and saw that it was the call from his apprentice Li Hua.

"Boss, someone is looking for the office."

……

……

Shao Fanxing is the general manager of Tianhai Pharmaceutical Group.

Now, he is standing in the office, a little excited and a little nervous.

Although the clinical trial of the compound "T cell adhesion agent STI-217" has not yet passed, these Chinese pharmaceutical companies are about to start preparing for bidding.

It takes time to build factories, and it takes time to organize production.

Waiting for the approval of HFDA to bid for production rights is too late.

The current situation of domestic pharmaceutical companies is very miserable.

R&D is no match for Europe and the United States.

Imitation will not kill India and Thailand.

Therefore, some pharmaceutical companies chose to pick up leftovers from European and American pharmaceutical companies to see if they could pick out anything to eat.

For just one penicillin, all major pharmaceutical companies can fight for who sells it cheaper.Although the technical level of penicillin is not high, and the patent period has expired, anyone can produce it, but the advantage is that it is used in large quantities!Small profits but quick turnover can also make money.

There are also some pharmaceutical companies that cooperate with major universities and hospitals to research and produce Chinese patent medicines.

Chinese patent medicines are supported by national policies.The price of the same medicine can be dozens of times higher under the name of "health care product".

However, pharmaceutical companies engaged in proprietary Chinese medicines are not doing well.

After all, it is still unclear whether "Chinese medicine" is useful or not.

And most people can't tell the difference between "Ancient Chinese Alchemy" and "Modern Improved and Upgraded Version of Traditional Chinese Medicine"; so much so that when they see "Chinese style" and "medicine" together, they like to use one size fits all and insult them all. Present yourself as a highly educated person.

In recent years, such pharmaceutical companies have also faced a lot of doubts and pressures.

Therefore, the current situation is that domestic pharmaceutical companies urgently need to change careers.Get rid of the status of cheap labor in the pharmaceutical industry and go out of your own way.

The newly developed targeted drug is a good opportunity.

Before coming, Shao Fanxing had already been told by the leader that he would make Qiao Yu agree to speak for them regardless of the cost.

Shao Fanxing was puzzled: "Qiao Yu is a scientific researcher, can he talk?"

He has met too many researchers.

When researchers came to ask them about these pharmaceutical companies asking for funds and seeking cooperation, they always smiled and promised.

Whether it is an ordinary scientific researcher or a professor-level scientific researcher, he must be supported. After all, a penny is hard for a hero, and he is the father who gives money on behalf of the company.

Shao Fanxing couldn't respect them because of their appearance.

Unexpectedly, now, the leader slapped him on the top of the head: "What's wrong with the scientific research, do you dare to look down on the scientific research? Let me tell you, Qiao Yu can not only speak, but also has a lot of power to speak. Do you believe that?" Do not believe?"

"Why is this?"

"Based on the 14 billion people in the country, there may not be another Qiao Yu in 50 years. The higher authorities will confess him. Why do you think?"

In short, Shao Fanxing came here to make friends with Professor Qiao.

Ten minutes later, Qiao Yu came back.

Shao Fanxing hurriedly greeted him with a smile on his face: "Hello, Professor Qiao, I am the representative of Tianhai Pharmaceutical Group, and my name is Shao Fanxing."

Qiao Yu poured himself a glass of water, glanced at the people beside him, and asked Li Hua, "What are you doing here?"

Li Hua: "Oh...it seems to be a donation."

Qiao Yu had a puzzled expression: "Donation?"

Shao Fanxing coughed: "Professor Qiao, is it convenient to talk in private?"

Yes, Shao Fanxing's strategy was to spend money.

He is in his forties, and it is really difficult to be friends with Professor Qiao, who is in his 20s.

Shao Fanxing had a good idea. In the name of scientific research funding, he gave Qiao Yu five million yuan. Wouldn't he be called a brother by then?

It is difficult for most domestic scholars to earn so much money.

Few people can refuse the temptation of 500 million.

Shao Fanxing's family property is over ten million, and he can't refuse five million.

Of course, it is also possible to give Qiao Yu 500 million, reimburse 550 million to the higher-ups, and act as a middleman to earn the difference of 50.

"Don't you want to donate money? What did you say in private?" Qiao Yu's expression was half a smile, "Li Hua, get Mr. Shao a watch."

Shao Fanxing was a little bit hard to get off.

He only hated Qiao Yu for being a stick, but he couldn't understand hints.